Practical issues in CAR T-cell therapy
Blood Research
;
: 11-12, 2023.
Article
in English
| WPRIM
| ID: wpr-999717
ABSTRACT
Chimeric antigen receptor (CAR) T-cell therapy presents a revolutionary advancement in personalized cancer treatment. During the production process, the patient's own T-cells are genetically engineered to express a synthetic receptor that binds to a tumor antigen. CAR T-cells are then expanded for clinical use and infused back into the patient's body to attack cancer cells. Although CAR T-cell therapy is considered a major breakthrough in cancer immunotherapy, it is not without limitations. In this review, we discuss the barriers to effective CAR T-cell therapy in Korea.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Blood Research
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS